(+035) 527-1710-70
NEW STOCK SYMBOL ETBI
EASTGATE ACQUISITIONS ANNOUNCES NAME CHANGE TO EASTGATE BIOTECH CORP. AND NEW STOCK SYMBOL
SALT LAKE CITY and TORONTO, December 15, ...
09
Dec
Press Releases
09
Mar
EASTGATE ACQUISITIONS ANNOUNCES COMPLETION OF PRIVATE EQUITY INVESTMENT FINANCING
SALT LAKE CITY and TORONTO, Mar. 10, 2014 /PRNewswire/ — EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceuti...
09
Mar
EASTGATE ACQUISITIONS PRESENTS AN INTRODUCTION TO ITS SELF-EMULSIFYING PLATFORM DELIVERY SYSTEM FOR ENHANCING BIOAVAILABILITY OF BIOLOGICALLY ACTIVE COMPOUNDS
SALT LAKE CITY and TORONTO, May 20, 2014 (PRNewswire/-) EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical...
09
Mar
EASTGATE ACQUISITIONS ANNOUNCES PRESENTATION AT STE’S 3 ANNUAL MICROCAP INVESTOR CONFERENCE
SALT LAKE CITY and TORONTO, May 28, 2014 /PRNewswire/ — EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceut...
09
Mar
EASTGATE ACQUISITIONS ENTERS INTO WORKING COLLABORATION WITH LEADING NEUROLOGIST AT TORONTO WESTERN HOSPITAL
SALT LAKE CITY and TORONTO, June 17, 2014 /PRNewswire/ — EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceuti...
09
Mar
EASTGATE ACQUISITIONS RECEIVES RESEARCH GRANT FROM ONTARIO BRAIN INSTITUTE
SALT LAKE CITY and TORONTO, June 25, 2014 /PRNewswire/– EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical...
09
Mar
EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology
New pharmaceutical development opens up entry into blockbuster markets
SALT LAKE CITY and TORONTO, July 29, 2014 /PRNewswire/ — ...
09
Mar
A transmucosal Lorazepam spray for treatment of acute seizures: Summary
A transmucosal Lorazepam spray for treatment of acute seizures: Summary
The estimated annual incidence of prolonged epileptic se...
09
Mar
EASTGATE ACQUISITIONS ENTERS INTO A LICENSE AGREEMENT WITH PURINE PHARMA LLC FOR MARKETING AND DISTRIBUTION OF ITS NUTRACEUTICAL AND CONSUMER PRODUCT LINE
SALT LAKE CITY and TORONTO, September 29, 2014 (PRNewswire/-) EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmace...
09
Mar
EASTGATE ACQUISITIONS AUGMENTS ITS SUB-MICRON SELF-NANOEMULSIFYING PLATFORM TECHNOLOGY
Broad spectrum of delivery forms is directed towards improving patient compliance
SALT LAKE CITY and TORONTO, August 15 , 2014 (...